My CPNP provides quick access to the most important features on

You will see your important notices, and you will have direct access to your exams and other action items.

Log in now to see your personalized page.

User login

Industry News

Paone D, Tuazon E, Stajic M, et al. Buprenorphine infrequently found in fatal overdose in New York City. drug Alcohol Depend 2015. doi:10.1016/j.drugalcdep.2015.08.007.
BACKGROUND: Buprenorphine is an opioid agonist medication that is both safe and effective in the treatment of opioid use disorders and the prevention of opioid overdoses. Despite this, media coverage has highlighted public concerns about the potential safety consequences of buprenorphine misuse and diversion. To address the possible contribution of buprenorphine to overdose mortality, we systematically tested post mortem blood specimens from decedents who had died of an unintentional drug overdoses in 2013...
Korhonen T, Smeds E, Silventoinen K, Heikkilä K, Kaprio J. Cigarette smoking and alcohol use as predictors of disability retirement: A population-based cohort study. drug Alcohol Depend 2015. doi:10.1016/j.drugalcdep.2015.06.047.
BACKGROUND: This study investigated how cigarette smoking and alcohol use predict disability retirement. METHODS: Data from the longitudinal nationwide Finnish Twin Cohort study were analyzed, with clustered study design applied when computing 95% confidence intervals (CI). The sample included 21,719 individuals. Smoking and alcohol use were assessed with a questionnaire in 1975. Registry data on retirement events up till end of 2004 were obtained from the Social Insurance Institution and the Finnish...


CPNP Announces 2015-2016 Board of Directors

July 1 marks the start of College of Psychiatric and Neurologic Pharmacists’ (CPNP) fiscal year and the transition of officers on the Board of Directors. CPNP Board leaders for 2015-2016 include:

College of Psychiatric and Neurologic Pharmacists Releases Updated Psychiatric Pharmacy Manifesto

As an organization, the College of Psychiatric and Neurologic Pharmacists (CPNP) is committed to developing and promoting pharmacists who practice in the specialty areas of psychiatry and neurology. One method to maximize this visibility is through CPNP’s Psychiatric Pharmacy Manifesto. Just recently, the CPNP Past Presidents updated the manifesto with the goal that it serve as a public declaration of our principles, beliefs, and intentions to those within and outside our profession. The updated manifesto is available here.

The College of Psychiatric and Neurologic Pharmacists (CPNP) Announces Saklad Memorial Award and Research Award Recipients Presented at the 2015 CPNP Annual Meeting

Judith J. Saklad Memorial Award

CPNP was honored to present the Judith J. Saklad Memorial Award at the 2015 CPNP Annual Meeting for the eighteenth time. This award celebrates the life and work of the late Judith J. Saklad. Dr. Saklad was a founding member of CPNP and nationally recognized as an innovator of pharmaceutical care to children and adults with serious mental disorders, developmental and intellectual disabilities. The 2015 recipient is Dr. Carla Cobb.

College of Psychiatric and Neurologic Pharmacists (CPNP) 2015 Annual Meeting

Tampa, Florida served as host city for the College of Psychiatric and Neurologic Pharmacist’s 18th Annual Meeting held April 19-22. This four-day conference hosted 656 attendees and featured nearly 30 hours of cutting-edge scientific presentations, one industry supported symposium, three product theaters and a display of 186 scientific posters. Jacquelyn Canning, PharmD, BCPP, Assistant Professor, Albany College of Pharmacy and Health Sciences, Albany, NY, served as Program Chair of the CPNP Annual Meeting.

College of Psychiatric and Neurologic Pharmacists Releases Practical Guidelines on Naloxone Access for Pharmacists

The College of Psychiatric & Neurologic Pharmacists (CPNP) and members of its Substance Abuse Task Force are pleased to announce the release of a guideline document intended to educate pharmacists on naloxone use and administration with the goal of providing increased patient access to this life-saving medication for opioid overdose. NALOXONE ACCESS: A Practical Guideline for Pharmacists, provides information on the following:

CPNP Joins PCSS-O and PCSS-MAT Steering Committees

To better prepare pharmacists and other providers to meet the rising demand for services and solutions regarding opioid use disorders and treatment, CPNP recently joined the steering committees of PCSS-O and PCSS-MAT (Provider’s Clinical Support System for Opioid Therapies and Medication Assisted Therapies, respectively).

CPNP Announces 2015 Research Award Finalists

A record number 195 abstracts will be featured at the CPNP Annual Meeting. Posters will be displayed Monday, April 20, 2015 between 8:00 a.m. and 7:15 p.m. Students, residents, and fellows will man their posters for a 1 hour segment in the morning while all other posters and award posters will be manned during a 1 hour evening event. Conversations and networking can continued during the reception that concludes Monday evening. A special thank you to the abstract reviewers who participated in making these selections.

CPNP Releases Position Paper on Psychiatric Pharmacists as an Essential Member of Every Healthcare Team

The College of Psychiatric & Neurologic Pharmacists (CPNP) has developed an official position paper to help increase patient access to comprehensive medication management and to support efforts to obtain payment for the service.

College of Psychiatric and Neurologic Pharmacists Announces Election of 2015-2017 Officers

The College of Psychiatric and Neurologic Pharmacists (CPNP) membership has elected three officers to serve on the 2015-2017 Board of Directors. Assuming their offices effective July 1, 2015, will be Drs. Sara Dugan, Robert Haight, and Christopher Thomas.

Newly elected Board members will fill the following roles on the Board:

If you have any questions, please contact us.